| Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement FE Stuurman, B Nuijen, JH Beijnen, JHM Schellens Clinical pharmacokinetics 52, 399-414, 2013 | 155 | 2013 |
| Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings RCA Schellekens, F Stellaard, D Mitrovic, FE Stuurman, JGW Kosterink, ... Journal of controlled release 132 (2), 91-98, 2008 | 117 | 2008 |
| A novel dissolution method relevant to intestinal release behaviour and its application in the evaluation of modified release mesalazine products RCA Schellekens, FE Stuurman, FHJ Van der Weert, JGW Kosterink, ... European journal of pharmaceutical sciences 30 (1), 15-20, 2007 | 96 | 2007 |
| Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial JAAC Heuberger, JI Rotmans, P Gal, FE Stuurman, J van't Westende, ... The Lancet Haematology 4 (8), e374-e386, 2017 | 74 | 2017 |
| Repeatability and predictive value of lactate threshold concepts in endurance sports JAAC Heuberger, P Gal, FE Stuurman, WAS de Muinck Keizer, ... PloS one 13 (11), e0206846, 2018 | 53 | 2018 |
| Development of novel, value-based, digital endpoints for clinical trials: a structured approach toward fit-for-purpose validation MD Kruizinga, FE Stuurman, V Exadaktylos, RJ Doll, DT Stephenson, ... Pharmacological Reviews 72 (4), 899-909, 2020 | 41 | 2020 |
| Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors FE Stuurman, EE Voest, A Awada, PO Witteveen, T Bergeland, PA Hals, ... Investigational new drugs 31, 959-966, 2013 | 33 | 2013 |
| A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir VA de Weger, FE Stuurman, JJMA Hendrikx, JJ Moes, E Sawicki, ... European Journal of Cancer 86, 217-225, 2017 | 26 | 2017 |
| Technical validity and usability of a novel smartphone‐connected spirometry device for pediatric patients with asthma and cystic fibrosis MD Kruizinga, E Essers, FE Stuurman, A Zhuparris, N van Eik, ... Pediatric Pulmonology 55 (9), 2463-2470, 2020 | 24 | 2020 |
| A phase I dose escalation study of once-weekly oral administration of docetaxel as ModraDoc001 capsule or ModraDoc006 tablet in combination with ritonavir VA de Weger, FE Stuurman, SLW Koolen, JJ Moes, JJMA Hendrikx, ... Clinical Cancer Research 25 (18), 5466-5474, 2019 | 22 | 2019 |
| A novel somatostatin-dopamine chimera (BIM23B065) reduced GH secretion in a first-in-human clinical trial WMI de Boon, MJ van Esdonk, FE Stuurman, NR Biermasz, L Pons, I Paty, ... The Journal of Clinical Endocrinology & Metabolism 104 (3), 883-891, 2019 | 20 | 2019 |
| The future of clinical trial design: the transition from hard endpoints to value-based endpoints MD Kruizinga, FE Stuurman, GJ Groeneveld, AF Cohen Concepts and Principles of Pharmacology: 100 Years of the Handbook of …, 2019 | 20 | 2019 |
| Cerebrovascular events during nilotinib treatment NG Jager, FE Stuurman, JW Baars, FL Opdam Neth J Med 72 (2), 113-4, 2014 | 18 | 2014 |
| Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA+ rheumatoid arthritis A Sonigra, HJ Nel, P Wehr, N Ramnoruth, S Patel, KA van Schie, ... JCI insight 7 (20), 2022 | 17 | 2022 |
| Towards remote monitoring in pediatric care and clinical trials—Tolerability, repeatability and reference values of candidate digital endpoints derived from physical activity … MD Kruizinga, N Heide, A Moll, A Zhuparris, Y Yavuz, ML Kam, ... PloS one 16 (1), e0244877, 2021 | 15 | 2021 |
| Phase I study of weekly oral docetaxel (ModraDoc001) plus ritonavir in patients with advanced solid tumors. S Marchetti, F Stuurman, S Koolen, J Moes, J Hendrikx, B Thijssen, ... Journal of Clinical Oncology 30 (15_suppl), 2550-2550, 2012 | 15 | 2012 |
| Sensitivity and specificity of detection methods for erythropoietin doping in cyclists JAAC Heuberger, P Van Eenoo, JI Rotmans, P Gal, FE Stuurman, TE Post, ... Drug testing and analysis 11 (9), 1290-1301, 2019 | 12 | 2019 |
| A Phase 1 Comparative Pharmacokinetic and Cardiac Safety Study of Two Intravenous Formulations of CO‐101 in Patients With Advanced Solid Tumors FE Stuurman, MP Lolkema, ADR Huitema, P Soetekouw, H Rosing, ... The Journal of Clinical Pharmacology 53 (8), 878-883, 2013 | 11 | 2013 |
| Immunomonitoring of tacrolimus in healthy volunteers: the first step from PK-to PD-based therapeutic drug monitoring? AE in ‘t Veld, HW Grievink, M Saghari, FE Stuurman, ML de Kam, ... International Journal of Molecular Sciences 20 (19), 4710, 2019 | 10 | 2019 |
| Pharmacokinetic evaluation of three oral formulations of docetaxel boosted with ritonavir: two single-drug formulations vs. a fixed-dose combination tablet JJ Moes, FE Stuurman, JJMA Hendrikx, S Marchetti, ADR Huitema, ... Drug delivery and translational research 3, 243-251, 2013 | 10 | 2013 |
Pim Gal MD PhDCentre for Human Drug ResearchGeverifieerd e-mailadres voor chdr.nl
